Valter Niemelä

5PUBLICATIONS
1CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsGene expression (incl. microarray and other genome-wide approaches)Epigenetics (incl. genome methylation and epigenomics)Central nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 12, 2026
Decreased cerebrospinal fluid TNFRSF8 (sCD30) confirmed as a biomarker of Huntington's disease progression.

|Jan 28, 2026
Novel Clinical Insights From a Swedish RFC1 Spectrum Disorder Cohort.

Victor Alm, Linda Säll, Kristin Samuelsson

|Jan 16, 2026
Lifetime risk of cancer in carriers of intermediate alleles in the HTT gene.

Jimmy Sundblom, Ingvar Bergdahl, Eva-Lena Stattin

|Feb 24, 2018
Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease.

Valter Niemelä, Joachim Burman, Kaj Blennow

|Feb 28, 2017
Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?

Valter Niemelä, Anne-Marie Landtblom, Kaj Blennow

Pageof 1

Frequent Collaborators

1 joint publications

Victor Alm